Search

Your search keyword '"Manfredi, S."' showing total 86 results

Search Constraints

Start Over You searched for: Author "Manfredi, S." Remove constraint Author: "Manfredi, S." Search Limiters Full Text Remove constraint Search Limiters: Full Text Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
86 results on '"Manfredi, S."'

Search Results

1. Emphysematous cystitis: review of current literature, diagnosis and management challenges

2. Nursing schools and academic health centers: toward improved alignment and a synergistic partnership

3. LBA28 Prognostic effect of imaging and CEA follow-up in resected colorectal cancer (CRC): Final results and relapse free survival (RFS) - PRODIGE 13 a FFCD phase III trial

4. Classical and Modern Standard Arabic

5. 481P Evaluation of serum mid-infrared spectroscopy as new prognostic marker for bevacizumab-based chemotherapy in first-line treatment of metastatic colorectal cancer

6. Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child-Pugh B cirrhosis

7. 522TiP PRODIGE 71 - BEVAMAINT: A randomized phase III study comparing maintenance treatment with fluoropyrimidine + bevacizumab versus fluoropyrimidine after induction chemotherapy for a metastatic colorectal cancer

8. 52P Modified FOLFIRINOX versus CISGEM as first-line chemotherapy for advanced biliary tract cancer: Results of AMEBICA PRODIGE 38 randomized phase II trial

9. 398O Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer (CRC) - PRODIGE 13 a FFCD phase III trial

10. Nal-iri/lv5-fu versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study

11. Effect of a commercially available fish-based dog food enriched with nutraceuticals on hip and elbow dysplasia in growing Labrador retrievers

12. ARCAD-NADEGE cohort: Result of a small bowel adenocarcinomas prospective cohort

13. Inguinal Hernia: Mesh Fixation

14. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.

15. 842TiP - Nal-iri/lv5-fu versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study

16. PRODIGE 50 - ASPIK French: French double blind randomised study of aspirin versus placebo in resected stage III or high risk stage II colon cancer with PIK3CA mutation

17. PRODIGE 51 - GASTFOX: Phase III randomised trial evaluating FOLFOX with or without DOCETAXEL (TFOX) as 1st line chemotherapy for locally advanced or metastatic oesophago-gastric adenocarcinoma

19. Cholecystocutaneous fistula containing multiple gallstones in a dog

22. 773TiP - PRODIGE 51 - GASTFOX: Phase III randomised trial evaluating FOLFOX with or without DOCETAXEL (TFOX) as 1st line chemotherapy for locally advanced or metastatic oesophago-gastric adenocarcinoma

28. Consensus-based algorithm for distributed estimation of the maximum of a field

29. A Resilient Consensus Protocol for Networks With Heterogeneous Confidence and Byzantine Adversaries

30. On Adversary Robust Consensus Protocols Through Joint-Agent Interactions

31. Distributed PI Control For Heterogeneous Nonlinear Platoon of Autonomous Connected Vehicles

32. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

33. Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

34. A Petri Net approach to consensus in networks with joint-agent interactions

35. On consensus protocols allowing joint-agent interactions

36. Design and experimental testing of an optimization-based flow control algorithm for Energy Harvesting Wireless Sensor Networks

37. Arabic borrowing of the Hebrew word menahēl ‘manager’: Articulations and ideologies

38. Mobility and Congestion in Dynamical Multilayer Networks with Finite Storage Capacity

39. Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases.

40. Impact of a Tripartite Collaboration between Oncologist, Pharmacist and Diabetologist in the Management of Patients with Diabetes Starting Chemotherapy: The ONCODIAB Trial.

41. Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter study.

42. Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world setting.

43. Biliary tract cancers have distinct epidemiological patterns and clinical characteristics according to tumour site.

44. Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma.

46. Daily practices in chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma: METESTOMAC French prospective cohort.

47. Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD).

48. Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer.

49. Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer.

50. Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice.

Catalog

Books, media, physical & digital resources